Portfolio company
Artera
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Spotlight Medical
This company develops AI-driven prognosis tests to help oncologists select the most effective treatments for cancer patients.
Ataraxis AI
This company develops artificial intelligence models that predict cancer outcomes and treatment responses for healthcare providers and oncologists.
Ataraxis
The company develops artificial intelligence diagnostic tools for breast cancer to help clinicians predict treatment response and recurrence risk from patient data.
Waiv
This company develops artificial intelligence diagnostic tests and digital pathology software for oncology laboratories and healthcare providers to improve cancer patient treatment decisions.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Orbit Genomics
This company develops AI-powered genomic tests for healthcare providers and patients to diagnose lung cancer and evaluate risks for chronic diseases.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
